Digital Biomarkers,
Journal Year:
2021,
Volume and Issue:
5(3), P. 216 - 223
Published: Sept. 13, 2021
The
assessment
of
health
and
disease
requires
a
set
criteria
to
define
status
progression.
These
measures
are
referred
as
“endpoints.”
A
“digital
endpoint”
is
defined
by
its
use
sensor-generated
data
often
collected
outside
clinical
setting
such
in
patient’s
free-living
environment.
Applicable
sensors
exist
an
array
devices
can
be
applied
diverse
contexts.
For
example,
smartphone’s
microphone
might
used
diagnose
or
predict
mild
cognitive
impairment
due
Alzheimer’s
wrist-worn
activity
monitor
(such
those
found
smartwatches)
may
measure
drug’s
effect
on
the
nocturnal
patients
with
sickle
cell
disease.
Digital
endpoints
generating
considerable
excitement
because
they
permit
more
authentic
experience,
reveal
formerly
untold
realities
burden,
cut
drug
discovery
costs
half.
However,
before
these
benefits
realized,
effort
must
not
only
technical
creation
digital
but
also
environment
that
allows
for
their
development
application.
future
rests
meaningful
interdisciplinary
collaboration,
sufficient
evidence
realize
promise,
ecosystem
which
vast
quantities
generate
analyzed.
fundamental
nature
care
changing.
With
coronavirus
2019
serving
catalyst,
there
has
been
rapid
expansion
home
models,
telehealth,
remote
patient
monitoring.
increasing
adoption
health-care
innovations
will
expedite
requirement
characterization
current
tools
rely
upon
direct
interaction
thus
fit
purpose
administered
remotely.
ubiquity
relatively
inexpensive
sensors,
positioned
drive
this
consequential
change.
It
therefore
surprising
regulators,
physicians,
researchers,
consultants
have
each
offered
novel
tools.
we
further
describe
later,
broad
require
cooperative
effort.
In
article,
present
analysis
state
endpoints.
We
attempt
unify
perspectives
parties
involved
deployment
conclude
interdependent
list
challenges
collaboratively
addressed
widely
adopted.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(22), P. 16119 - 16119
Published: Nov. 9, 2023
With
the
inexorable
aging
of
global
populace,
neurodegenerative
diseases
(NDs)
like
Alzheimer’s
disease
(AD),
Parkinson’s
(PD),
and
amyotrophic
lateral
sclerosis
(ALS)
pose
escalating
challenges,
which
are
underscored
by
their
socioeconomic
repercussions.
A
pivotal
aspect
in
addressing
these
challenges
lies
elucidation
application
biomarkers
for
timely
diagnosis,
vigilant
monitoring,
effective
treatment
modalities.
This
review
delineates
quintessence
realm
NDs,
elucidating
various
classifications
indispensable
roles.
Particularly,
quest
novel
AD,
transcending
traditional
markers
PD,
frontier
biomarker
research
ALS
scrutinized.
Emergent
susceptibility
trait
herald
a
new
era
personalized
medicine,
promising
enhanced
initiation
especially
cases
SOD1-ALS.
The
discourse
extends
to
diagnostic
state
markers,
revolutionizing
early
detection
alongside
progression
that
unveil
trajectory
propelling
forward
potential
tailored
interventions.
synergy
between
burgeoning
technologies
innovative
techniques
-omics,
histologic
assessments,
imaging
is
spotlighted,
underscoring
roles
discovery.
Reflecting
on
progress
hitherto,
underscores
exigent
need
multidisciplinary
collaborations
surmount
ahead,
accelerate
discovery,
epoch
understanding
managing
NDs.
Through
panoramic
lens,
this
article
endeavors
provide
comprehensive
insight
into
field
spotlighting
promise
they
hold
transforming
landscape,
enhancing
management,
illuminating
pathway
toward
efficacious
therapeutic
Expert Review of Neurotherapeutics,
Journal Year:
2024,
Volume and Issue:
24(2), P. 201 - 216
Published: Jan. 18, 2024
Introduction
While
magnetic
resonance
imaging
(MRI)
is
established
in
diagnosing
and
monitoring
disease
activity
multiple
sclerosis
(MS),
its
utility
predicting
progression
less
clear.
Frontiers in Neurology,
Journal Year:
2018,
Volume and Issue:
9
Published: Oct. 11, 2018
Multiple
sclerosis
is
a
debilitating
disorder
resulting
from
scattered
lesions
in
the
central
nervous
system.
Because
of
high
variability
lesion
patterns
between
patients,
it
difficult
to
relate
existing
biomarkers
symptoms
and
their
progression.
The
nature
multiple
offers
itself
be
studied
through
lens
network
analyses.
Recent
research
into
has
taken
such
approach
by
making
use
functional
connectivity.
In
this
review,
we
briefly
introduce
measures
connectivity
how
compute
them.
We
then
identify
several
common
observations
approach:
(a)
likelihood
altered
deep-gray
matter
regions,
(b)
decrease
brain
modularity,
(c)
hemispheric
asymmetries
alterations,
(d)
correspondence
behavioral
with
task-related
task-unrelated
networks.
propose
incorporating
analyses
longitudinal
studies
order
improve
our
understanding
underlying
mechanisms
affected
sclerosis,
which
can
consequently
offer
promising
route
individualizing
imaging-related
for
sclerosis.
Proceedings of the National Academy of Sciences,
Journal Year:
2017,
Volume and Issue:
114(33)
Published: July 31, 2017
Significance
Cells
from
the
innate
immune
system,
namely
microglia
and
macrophages
(mononuclear
phagocytes,
MPs),
play
a
central
role
in
progression
of
neurological
disorders
such
as
multiple
sclerosis.
Such
cells
can
contribute
to
lesion
formations
(proinflammatory)
or
participate
remyelinating
processes
(neuroprotective).
When
differentiated
proinflammatory
phenotype,
MPs
experience
metabolic
reprogramming
leading
increased
glycolysis
production
lactate.
In
this
study
we
showed
that
new
imaging
method,
13
C
magnetic
resonance
spectroscopic
(MRSI)
hyperpolarized
pyruvate,
detect
lactate
MPs,
mechanism
mediated
by
pyruvate
dehydrogenase
kinase
1
upregulation,
preclinical
model
These
findings
validate
potential
MRSI
for
vivo
detection
neuroinflammation.
Frontiers in Aging Neuroscience,
Journal Year:
2019,
Volume and Issue:
11
Published: May 10, 2019
Increasingly
favorable
mortality
prognosis
in
multiple
sclerosis
(MS)
raises
questions
regarding
MS-specific
cognitive
aging
and
the
presence
of
comorbidities
such
as
Alzheimer's
disease
(AD).To
assess
elderly
with
MS
(EwMS)
age-matched
healthy
controls
(HCs)
using
both
MS-
AD-specific
psychometrics.EwMS
(n
=
104)
56
HCs
were
assessed
on
a
broad
spectrum
language,
visual-spatial
processing,
memory,
processing
speed,
executive
function
tests.
Using
logistic
regression
analysis,
we
examined
performance
differences
between
EwMS
HC
groups.
Cognitive
impairment
(CI)
was
defined
-1.5
SD
threshold
relative
to
age
education
years-matched
HCs,
two
domains.CI
observed
47.1%
most
often
seen
tests
emphasizing
speed
measured
by
Symbol
Digit
Modalities
Test
(SDMT)
(d
0.9,
p
<
0.001)
verbal
fluency
(both
category-based
d
0.87,
0.001;
letter-based
0.67,
0.001).
After
adjusting
for
age,
sex
years
education,
MS/HC
diagnosis
best
predicted
(R2
0.27)
(Wald
9.935,
0.002)
SDMT
13.937,
0.001).This
study
confirms
common
hallmark
slowed
among
patients.
Defective
fluency,
less
younger
cohorts,
may
represent
emerging
pathology
due
other
etiologies.
Occupational Therapy In Health Care,
Journal Year:
2021,
Volume and Issue:
35(3), P. 306 - 317
Published: June 14, 2021
The
Canadian
Occupational
Performance
Measure
(COPM)
is
a
generic
questionnaire
based
on
semi-structured
interview.
We
aimed
to
translate
Turkish
version
of
the
COPM
(COPM-TR)
and
assess
its
reliability
validity.
COPM-TR
was
administered
82
participants
(42.2
±
11.6
years
32.9%
were
male)
with
multiple
sclerosis
(MS)
for
convergent
validity
analysis.
Multiple
Sclerosis
Quality
Life-54
(MSQoL-54),
Expanded
Disability
Status
Scale
(EDSS)
determine
Test-retest
(a
week
interval)
assessed
by
Intraclass
Correlation
Coefficient
(ICC).
There
moderately
strong
negative
correlations
between
EDSS
performance
satisfaction
score
COPM-TR.
positive
MSQoL-54
physical
moderate
Moderate
found
mental
scores.
Test
re-test
indicated
excellent
reliability.
current
study
demonstrates
that
valid
reliable
tool
measuring
perceived
occupational
people
MS.
Health and Quality of Life Outcomes,
Journal Year:
2022,
Volume and Issue:
20(1)
Published: Nov. 25, 2022
Abstract
Background
Lifestyle
self-management
as
an
intervention
for
people
living
with
multiple
sclerosis
(plwMS)
is
emerging
area
of
research.
Previous
reviews
have
highlighted
a
need
to
systematically
identify
effective
regimens
that
influence
the
health
and
well-being
plwMS
using
common
metric
success.
Objectives
To
examine
effectiveness
lifestyle
strategies
interventions
aimed
at
improving
quality
life
(QOL),
and/or
disability
plwMS.
The
review
also
narratively
explore
elements
were
outcomes
interest.
Methods
A
systematic
search
was
performed
five
scientific
databases.
process
followed
Cochrane
Handbook
Systematic
Reviews
Interventions
registered
PROSPERO
(Ref:
CRD42021235982).
Results
total
57
studies
including
5830
individuals
diagnosed
MS,
met
inclusion
criteria.
Self-management
included
physical
activity,
fatigue,
dietary,
stress/coping,
emotional,
symptom
medical
management,
wellbeing
programs.
Self-reported
QOL
improved
in
35
47
studies.
Dietary
had
no
statistically
significant
overall
effect
on
reducing
MS
disability,
(
P
=
0.18).
Heterogeneity
limited
ability
pool
effects
from
large
number
eligible
same
design.
Conclusion
Multicomponent
interventions,
multimodal
delivery
methods,
cognitive
behavioural
theory
principles
However,
these
results
should
be
interpreted
caution
care
taken
its
clinical
application.
This
has
potential
inform
future
management
practices
revealed
gap
literature,
warranting
high-quality,
large-scale
experimental,
observational
address
management.
F1000Research,
Journal Year:
2017,
Volume and Issue:
6, P. 1828 - 1828
Published: Oct. 12, 2017
Understanding
the
clinico-radiological
paradox
is
important
in
search
for
more
sensitive
and
specific
surrogates
of
relapses
disability
progression
(such
that
they
can
be
used
to
inform
treatment
choices
individual
people
with
multiple
sclerosis)
gain
a
better
understanding
pathophysiological
basis
sclerosis
(to
identify
assess
key
therapeutic
targets).
In
this
brief
review,
we
will
consider
themes
issues
underlying
recent
advances
its
resolution.